Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Coya Therapeutics Inc COYA

Healthcare Biotechnology
Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in developing treatments focused on the biology and potential therapeutic advantages of regulatory T cells (Tregs) to target systemic inflammation and neuroinflammation. Its initial developmental programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases of high unmet... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:COYA)

Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference

Business Wire 3 days ago

Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders

Business Wire 9 days ago

Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results

Business Wire November 6, 2024

Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer

Business Wire November 1, 2024

Coya Therapeutics Announces Conference Call to Report Results from an Investigator-Initiated Phase 2 Trial of Low-Dose Interleukin-2 in Patients with Mild to Moderate Alzheimer's Disease

Business Wire October 28, 2024

Coya Therapeutics Announces Closing of $10.0 Million Private Placement

Business Wire October 23, 2024

Coya Therapeutics Announces $10.0 Million Private Placement

Business Wire October 22, 2024

Coya Therapeutics Chairman and CEO Howard Berman Selected for PharmaVoice 100

Business Wire October 8, 2024

Coya Therapeutics to Participate in Fireside Chat at the Chardan 8th Annual Genetic Medicines Conference

Business Wire September 24, 2024
View More News ››

Opinion & Analysis (NDAQ:COYA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:COYA)

Coya Therapeutics, Inc. (NASDAQ:COYA): A Promising Biotech P

http://beyondspx.com/2024/07/31/coya-therapeutics-inc-nasdaqcoya-a-promising-biotech-poised-for-significant-growth/
MikeTester - August 2, 2024

Huge news to start the year for COYA!

https://youtu.be/SEh4ra1xKtM?si=mMoM3EDtm0zzlUhb
BryceCanada - January 4, 2024

New video out from COYA CEO

https://youtu.be/Hg5B8IbmRxU?si=4ybR64kYvKuRUVDW
BryceCanada - October 26, 2023

Excellent YT analysis on COYA!

https://youtu.be/0AmM1T6lkN0
BryceCanada - March 6, 2023
View more Bullboard ››

Promino Nutritional Sciences Inc.

Promino Nutritional Sciences Inc.

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical ...
View More »